Tag: clinical biostatistics

Automation and Reusability in TFL Programming Across Portfolios Automation and Reusability in TFL Programming Across Portfolios In clinical research, the preparation and generation of tables, figures, and listings (TFLs) are critical components of clinical study reports (CSRs). Automation and reusability in TFL programming can significantly enhance efficiency, reduce errors, and ensure compliance with relevant regulatory…

Read More “Automation and Reusability in TFL Programming Across Portfolios” »

Case Studies: TFL Design That Clarified—or Confused—Regulatory Reviewers In the realm of bladder cancer clinical trials, the proper design and presentation of Tables, Figures, and Listings (TFLs) is pivotal for effective regulatory submissions. This article serves as a step-by-step tutorial guide for clinical operations, regulatory affairs, and medical affairs professionals in the US, UK, and…

Read More “Case Studies: TFL Design That Clarified—or Confused—Regulatory Reviewers” »

Cross-Functional Review Workflows for TFL Accuracy and Consistency Cross-Functional Review Workflows for TFL Accuracy and Consistency In the realm of clinical trials, particularly in metformin clinical trials and other studies like ovarian cancer clinical trials, the accuracy and consistency of Tables, Figures, and Listings (TFLs) are paramount. This article aims to provide a comprehensive step-by-step…

Read More “Cross-Functional Review Workflows for TFL Accuracy and Consistency” »

Documenting TFL Specifications, Programs and Validation Evidence Documenting TFL Specifications, Programs and Validation Evidence In the realm of clinical trials, especially in the contexts governed by regulatory bodies such as the FDA, EMA, and MHRA, the proper documentation of tables, figures, and listings (TFLs) is critically important. For clinical operations, regulatory affairs, and medical affairs…

Read More “Documenting TFL Specifications, Programs and Validation Evidence” »

Preparing TFLs for Advisory Committees, Publications and HTA Dossiers Preparing TFLs for Advisory Committees, Publications and HTA Dossiers In clinical trial research, particularly in the domains of regulatory affairs and medical communications, the importance of well-prepared tables, figures, and listings (TFLs) cannot be overstated. This article offers a comprehensive step-by-step guide for clinical operations professionals,…

Read More “Preparing TFLs for Advisory Committees, Publications and HTA Dossiers” »

Summarizing Subgroup, Sensitivity and Exploratory Analyses in TFLs Clinical trials are a cornerstone of modern medical research and play a significant role in determining the safety and efficacy of new treatments. In this comprehensive guide, we will delve into the critical elements involved in summarizing subgroup, sensitivity, and exploratory analyses within Tables, Figures, and Listings…

Read More “Summarizing Subgroup, Sensitivity and Exploratory Analyses in TFLs” »

Handling Data Cut-Off, Snapshot and Re-Run Scenarios in TFL Production Handling Data Cut-Off, Snapshot and Re-Run Scenarios in TFL Production The landscape of clinical trials is intricate, especially when dealing with scenarios such as data cut-off, snapshots, and re-runs in the production of Tables, Figures, and Listings (TFL). This comprehensive guide focuses on how these…

Read More “Handling Data Cut-Off, Snapshot and Re-Run Scenarios in TFL Production” »

Integrating TFLs With Narratives, ISS/ISE and Integrated Summaries Integrating TFLs With Narratives, ISS/ISE and Integrated Summaries Integrating Tables, Figures, and Listings (TFLs) with narratives, Integrated Safety Summaries (ISS), and Integrated Efficacy Summaries (ISE) is a critical aspect of the Clinical Study Report (CSR) preparation process. This step-by-step tutorial aims to provide clinical operations, regulatory affairs,…

Read More “Integrating TFLs With Narratives, ISS/ISE and Integrated Summaries” »

Communicating Key Results to Regulators Through Well-Designed TFLs Communicating Key Results to Regulators Through Well-Designed TFLs In the ever-evolving landscape of clinical trials, particularly in the context of glp clinical trials, communicating results to regulatory bodies is paramount. This article aims to provide a comprehensive step-by-step tutorial on how to effectively convey key findings through…

Read More “Communicating Key Results to Regulators Through Well-Designed TFLs” »